Related Experiment Videos
The St Jude medical valve - the Australian experience
Insights
St. Jude medical cardiac valves show comparable hospital mortality rates to other prosthetic valves. Thromboembolic complications were less frequent with St. Jude valves when anticoagulation was maintained.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Prosthetic heart valves are crucial for treating valvular heart disease.
- The St. Jude Medical cardiac valve is a significant development in prosthetic valve technology.
Purpose of the Study:
- To evaluate the performance of St. Jude Medical cardiac valves in Australian patients.
- To compare the outcomes of St. Jude valve implantation with other prosthetic valves.
Main Methods:
- Retrospective analysis of 181 St. Jude Medical cardiac valve implantations in 166 patients.
- Data collection on implant types (single, combined, triple), hospital mortality, and thromboembolic complications.
Main Results:
- Hospital mortality rates were similar to existing prosthetic valve data.
- Lower incidence of thromboembolic complications observed in St. Jude valve recipients with proper anticoagulation.
- 152 single, 13 combined mitral/aortic, and 1 triple valve implants were performed.
Conclusions:
- St. Jude Medical cardiac valves demonstrate acceptable hospital mortality.
- Effective anticoagulation is key to reducing thromboembolic events in St. Jude valve patients.
- These valves represent a safe and effective option for cardiac valve replacement.
Abstract:
Since October, 1978, 181 St Jude medical cardiac valves have been implanted in 166 patients throughout Australia. There were 152 single implants, 13 combined mitral and aortic valve implants, and one triple valve implant. Hospital mortality rates were similar to those for all types of prosthetic cardiac valves. Thromboembolic complications occurred less frequently in the patients with St Jude valves than in reports of similar patients with other prostheses, provided that anticoagulation was maintained.